[NBY] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
14-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -40.79%
YoY- 34.50%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 2,170 1,615 3,142 4,091 3,438 1,200 152 55.68%
PBT -3,221 -282 -1,538 -2,447 -3,736 -5,240 -4,219 -4.39%
Tax 1,588 -2,149 -267 281 1,671 2 104 57.44%
NP -3,221 -282 -1,538 -2,447 -3,736 -5,242 -4,219 -4.39%
Tax Rate - - - - - - - -
Total Cost 5,391 1,897 4,680 6,538 7,174 6,442 4,371 3.55%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -148.43 -17.46 -48.95 -59.81 -108.67 -436.83 -2,775.66 -38.59%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -2.82 -0.54 -3.15 -5.60 -11.98 -62.04 -72.64 -41.78%
EPS Diluted -2.82 -0.43 -3.14 -5.59 -11.98 -62.04 -72.64 -41.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.